CB

Cabot CorpNYSE CBT Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

6.043

Middle

Exchange

XNYS - New York Stock Exchange, Inc

CBT Stock Analysis

CB

Neutral

Based on Eyestock quantitative analysis, CBT`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

77/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

7.1 %

Undervalued

Market cap $B

6.043

Dividend yield

1.59 %

Shares outstanding

56.324 B

Cabot Corp. is a global specialty chemicals and performance materials company. The company is headquartered in Boston, Massachusetts and currently employs 4,190 full-time employees. The firm operates through two reportable segments: Reinforcement Materials and Performance Chemicals. The Reinforcement Materials segment combines the reinforcing carbons and engineered elastomer composite product lines. Its reinforcing carbons products are used in tires and industrial products. The Performance Chemicals segment is organized into two businesses: its Performance Additives business and its Formulated Solutions business. The Performance Additives business combines its specialty carbons, battery materials, fumed metal oxides and aerogel product lines, and its Formulated Solutions business combines its specialty compounds and inkjet product lines. Its principal products are carbon black, specialty carbons, elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed silica and aerogel.

View Section: Eyestock Rating